Results 1 to 4 of 4

Thread: Two Questions About Half Life Times and Liver Protection

  1. #1
    Join Date
    Oct 2008
    Posts
    66

    Two Questions About Half Life Times and Liver Protection

    Hi
    im starting my 3rd cycle with sustanon 500/week + primo 600/week. Someone told me that i need to run testosterone 2 more weeks than primo due to its long half life and supression capacity. Is this true for primo too??? or only for deca?

    AND
    i will buy NAC during cycle for my liver (1200mg/day true???) and end of the cycle (in PCT) i will start TUDCA (500mg/day). But is this doses and timing are correct???

  2. #2
    Join Date
    Sep 2012
    Location
    NH
    Posts
    410
    Quote Originally Posted by X-BODY View Post
    Hi
    im starting my 3rd cycle with sustanon 500/week + primo 600/week. Someone told me that i need to run testosterone 2 more weeks than primo due to its long half life and supression capacity. Is this true for primo too??? or only for deca?

    AND
    i will buy NAC during cycle for my liver (1200mg/day true???) and end of the cycle (in PCT) i will start TUDCA (500mg/day). But is this doses and timing are correct???
    I would love to see what people have to say about udca. And what ester is the primo

  3. #3
    Join Date
    Aug 2009
    Posts
    13,506
    End the primo and test at the same time.
    And you don't need udca for that cycle (or NAC, really).

  4. #4
    When I'm on orals, I take 2g to 2.5g everyday of NAC. You don't really need NAC for injectables but I take 1g to 1.5g for liver support anyways.

Thread Information

Users Browsing this Thread

There are currently 1 users browsing this thread. (0 members and 1 guests)

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
Download FREE 396 Page Steroid Book/Guide!!

396 Pages of Anabolic Steroid resources, techniques and facts. Discover the best types of Steroids to use to reach specific goals and outcomes.